Leptomeningeal Cells Fire First in the Postnatal Brain’s Inflammatory Response
A systemic bacterial signal reached the newborn brain without breaching the blood-brain barrier, and the first responders were not neurons or deep parenchymal glia. In postnatal day 7 mice, a single intraperitoneal dose of lipopolysaccharide triggered an early intracranial immune reaction within 4 hours, led by leptomeningeal macrophages and followed by fibroblast activation across the arachnoid, pia, and perivascular compartments.
The sequence matters because it reframes the earliest phase of brain inflammation in the immature nervous system. Rather than requiring direct bacterial entry into brain tissue, the inflammatory program began at the interfaces that normally separate the brain from the systemic circulation. Those border cells responded fast, and their response was enough to recruit and reshape immune activity deeper inside the brain.
IL-1β and CCL2 Form the Initial Signaling Axis
Leptomeningeal macrophages produced IL-1β first. That cytokine appears to have functioned as the opening signal for a broader tissue-wide response, activating neighboring fibroblasts in the arachnoid, pia, and perivascular spaces. Once engaged, those fibroblasts produced CCL2, a chemokine with strong monocyte- and macrophage-recruiting properties that helps explain how the local response expanded from the meninges into the parenchyma.
The downstream consequence was measurable in the brain interior. Parenchymal macrophages and microglia increased in number and developed hypertrophy, consistent with activation rather than passive bystander status. In the context of an immature brain, that kind of shift is biologically consequential: an interface-limited trigger can still amplify into widespread innate immune activation, even while the blood-brain barrier remains intact.
The barrier itself stayed preserved up to 72 hours after LPS exposure. That finding narrows the mechanism to intracranial communication between border-associated macrophages, fibroblasts, and resident immune cells, rather than leakage-driven invasion of the brain parenchyma.
Saa3 Emerges as the Dominant Early Response Gene
Among the genes induced after LPS challenge, Saa3 rose quickly and reached its peak at 4 and 12 hours. Its expression was not confined to one cell type or one anatomical compartment. Leptomeningeal macrophages, fibroblasts in the leptomeninges, fibroblasts in the choroid plexus stroma, perivascular fibroblasts, and macrophages within the leptomeninges, perivascular space, and cerebellar medulla all showed increased Saa3 expression.
That broad distribution suggests a coordinated innate immune program rather than isolated cellular noise. Saa3 appears to mark an early priming state in which interface cells and migrating macrophages are already reprogramming the local immune environment before any structural evidence of barrier failure appears. The fact that leptomeningeal macrophages expressing Saa3 continued their developmental migration into the brain parenchyma gives the signal added weight: these cells were not merely activated in place, but were moving as part of the inflammatory response.
Irg1, Lcn2, and Cxcl9 Define Distinct Functional Branches
Three other transcripts peaked at the same early 4- and 12-hour windows: Irg1, Lcn2, and Cxcl9. Each was concentrated in a different cellular niche, which points to division of labor within the inflammatory cascade. Leptomeningeal macrophages prominently expressed Irg1, perivascular fibroblasts and choroid plexus epithelial cells expressed Lcn2, and leptomeningeal fibroblasts expressed Cxcl9.
Irg1 is especially relevant because it influenced the direction of the inflammatory response. In immune-metabolic terms, it likely participates in steering the response toward a specific activation state rather than a generic proinflammatory surge. Lcn2 carries a different biological function: by sequestering bacterial iron siderophores, it can limit microbial growth. In a setting of bacterial mimicry induced by LPS, that iron-withholding function fits neatly with the immediate host-defense program activated in the immature brain.
Cxcl9 adds another layer by implying targeted leukocyte signaling from the meninges. Its localization to leptomeningeal fibroblasts suggests that structural border cells were not passive scaffolds. They were active cytokine and chemokine producers, shaping where and how the immune response spread.
Migrating Macrophages and Fibroblasts Act as a Border Defense Unit
The most striking feature of this experiment is the cellular choreography. Leptomeningeal macrophages initiated the cascade, fibroblasts amplified it, and migrating macrophages carried the response inward. This is a border-defense model in which the meninges and adjacent fibroblasts function as an immune relay system for the postnatal brain.
In a preterm-like developmental context, that arrangement may be protective in the short term and harmful if prolonged or excessive. Early innate activation can help contain a systemic inflammatory insult before pathogens or inflammatory mediators reach deeper structures. At the same time, the same response may expose the developing brain to cytokine-driven injury, altered microglial maturation, and glial hypertrophy. The present findings do not measure long-term neurodevelopment, but they do map the earliest tissue response with unusual clarity.
One sentence captures the central biological point: the response began at the brain’s borders, not in its core.
Why the Early 4-Hour Window Matters
The 4-hour time point is not a minor procedural detail. It is the moment when the innate immune program first became visible at scale, with IL-1β release, Saa3 induction, and the earliest surge in Irg1, Lcn2, and Cxcl9 expression. By 12 hours, the same gene programs remained elevated, suggesting a sustained early phase rather than a transient spike.
For neonatal neuroinflammation, that timing supports a model in which the first hour to half-day after systemic infection is biologically decisive. Border-associated macrophages and fibroblasts are positioned to sense circulating danger signals immediately, and they can translate those cues into chemokine production, macrophage recruitment, and metabolic reprogramming long before the blood-brain barrier shows measurable disruption.
What This Mouse Model Clarifies About Immature Brain Injury
This study does not claim that every preterm infant with systemic infection will follow the same cellular script. It does show, however, that the postnatal brain has a defined border-immune circuitry capable of rapid inflammatory activation without frank vascular breakdown. The leptomeninges, perivascular spaces, and choroid plexus emerge as active immune interfaces rather than anatomical afterthoughts.
For clinicians and translational researchers, the implication is straightforward: preventing or blunting neonatal brain injury may require targeting the earliest border-cell response, not just late-stage microglial activation or barrier permeability. The unresolved issue is how durable these early transcriptomic shifts are, whether they resolve cleanly, and how much they influence later white matter or cognitive outcomes. The current data stop at the immediate inflammatory window, leaving the long arc of injury and repair unmeasured.